+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Laboratory and clinical studies on aztreonam in the pediatric field



Laboratory and clinical studies on aztreonam in the pediatric field



Japanese Journal of Antibiotics 38(11): 3343-3348



Laboratory and clinical studies were performed as follows on aztreonam (AZT), a new monobactam antibiotic. Pharmacokinetics Serum concentrations of AZT were measured in 1 patient given 20 mg/kg by intravenous bolus injection. The peak concentration was 100 micrograms/ml at 15 minutes, and T 1/2 was 1.85 hours. Clinical efficacy AZT was administrated intravenously to 10 patients in doses of 59.2-170.7 mg/kg (average 76.1 mg/kg) t.i.d. for 3-8 days (average 5.3 days); 5 with pneumonia, 1 with bronchitis, 1 with lymphadenitis, 1 with sepsis (suspected) and 2 with urinary tract infections. The overall efficacy rate was 80%, i.e., efficacy was excellent in 5, good in 3, fair in 1 and poor in 1. Bacteriological efficacy was excellent, i.e., 4 of 4 Gram-negative strains disappeared. Any clinical side effects and laboratory abnormalities were not observed. The above results suggest that AZT is a useful antibiotic for treating pediatric bacterial infections, especially due to Gram-negative bacteria.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 005787337

Download citation: RISBibTeXText

PMID: 4094067


Related references

Laboratory and clinical studies of aztreonam in the pediatric field. Japanese Journal of Antibiotics 38(11): 3300-3306, 1985

Fundamental and clinical studies of aztreonam in the pediatric field. Japanese Journal of Antibiotics 38(11): 3239-3262, 1985

Bacteriological pharmacokinetic and clinical studies on aztreonam in the pediatric field. Japanese Journal of Antibiotics 38(11): 3195-3216, 1985

Clinical experience with aztreonam in the pediatric field. Japanese Journal of Antibiotics 38(11): 3316-3322, 1985

Laboratory and clinical studies of PC-904 in pediatric field. Japanese Journal of Antibiotics 31(7): 359-362, 1978

Laboratory and clinical studies of cefuzonam in pediatric field. Japanese Journal of Antibiotics 40(2): 427-438, 1987

Laboratory and clinical studies of cefoperazone in pediatric field. Japanese Journal of Antibiotics 33(9): 899-909, 1980

Laboratory and clinical studies of sultamicillin in pediatric field. Japanese Journal of Antibiotics 41(12): 1923-1939, 1988

Laboratory and clinical studies of ceftazidime in the pediatric field. Japanese Journal of Antibiotics 37(3): 512-523, 1984

Laboratory and clinical studies on cefdinir in pediatric field. Japanese Journal of Antibiotics 43(8): 1424-1435, 1990

Laboratory and clinical studies on cefamandole in pediatric field. Japanese Journal of Antibiotics 32(11): 1091-1100, 1979

Laboratory and clinical studies on cefodizime in the pediatric field. Japanese Journal of Antibiotics 42(6): 1424-1435, 1989

Laboratory and clinical studies cefroxadine in pediatric field. Japanese Journal of Antibiotics 34(12): 1655-1662, 1981

Laboratory and clinical studies of 6059-S in pediatric field. Japanese Journal of Antibiotics 34(5): 800-816, 1981

Laboratory and clinical studies on norfloxacin in the pediatric field. Japanese Journal of Antibiotics 43(5): 808-825, 1990